335 related articles for article (PubMed ID: 11899786)
41. Aggregate cost of mammography screening in the United States: comparison of current practice and advocated guidelines.
O'Donoghue C; Eklund M; Ozanne EM; Esserman LJ
Ann Intern Med; 2014 Feb; 160(3):145. PubMed ID: 24658691
[TBL] [Abstract][Full Text] [Related]
42. Cost-effectiveness of opportunistic versus organised mammography screening in Switzerland.
de Gelder R; Bulliard JL; de Wolf C; Fracheboud J; Draisma G; Schopper D; de Koning HJ
Eur J Cancer; 2009 Jan; 45(1):127-38. PubMed ID: 19038540
[TBL] [Abstract][Full Text] [Related]
43. Mammography screening: an incremental cost effectiveness analysis of two view versus one view procedures in London.
Bryan S; Brown J; Warren R
J Epidemiol Community Health; 1995 Feb; 49(1):70-8. PubMed ID: 7707010
[TBL] [Abstract][Full Text] [Related]
44. Mammography screening: prospects and opportunity costs.
Navarro AM; Kaplan RM
Womens Health; 1996; 2(4):209-33. PubMed ID: 9421557
[TBL] [Abstract][Full Text] [Related]
45. Cost-effectiveness of extending screening mammography guidelines to include women 40 to 49 years of age.
Salzmann P; Kerlikowske K; Phillips K
Ann Intern Med; 1997 Dec; 127(11):955-65. PubMed ID: 9412300
[TBL] [Abstract][Full Text] [Related]
46. Mammography screening: an incremental cost effectiveness analysis of double versus single reading of mammograms.
Brown J; Bryan S; Warren R
BMJ; 1996 Mar; 312(7034):809-12. PubMed ID: 8608287
[TBL] [Abstract][Full Text] [Related]
47. Cost analysis of aggressive breast cancer screening.
Moskowitz M; Fox SH
Radiology; 1979 Jan; 130(1):253-6. PubMed ID: 103136
[TBL] [Abstract][Full Text] [Related]
48. Probabilistic cost-effectiveness modeling of different breast cancer screening policies in Slovenia.
Rojnik K; Naversnik K; Mateović-Rojnik T; Primiczakelj M
Value Health; 2008; 11(2):139-48. PubMed ID: 18380626
[TBL] [Abstract][Full Text] [Related]
49. Higher mammography screening costs without appreciable clinical benefit: the case of digital mammography.
Kerlikowske K; Hubbard R; Tosteson AN
J Natl Cancer Inst; 2014 Aug; 106(8):. PubMed ID: 25031310
[No Abstract] [Full Text] [Related]
50. Mammographic screening: measurement of the cost in a population based programme in Victoria, Australia.
Hurley SF; Livingston PM; Thane N; Quang L
J Epidemiol Community Health; 1994 Aug; 48(4):391-9. PubMed ID: 7964340
[TBL] [Abstract][Full Text] [Related]
51. Low-cost screening mammography.
Evens RG
AJR Am J Roentgenol; 1992 Aug; 159(2):430-1; author reply 431-2. PubMed ID: 1307858
[No Abstract] [Full Text] [Related]
52. Benefits and costs of screening and treatment for early breast cancer. Development of a basic benefit package.
Kattlove H; Liberati A; Keeler E; Brook RH
JAMA; 1995 Jan; 273(2):142-8. PubMed ID: 7799495
[TBL] [Abstract][Full Text] [Related]
53. Economic savings and costs of periodic mammographic screening in the workplace.
Griffiths RI; McGrath MM; Vogel VG
Oncology (Williston Park); 1996 Mar; 10(3):285-9; discussion: 289-94. PubMed ID: 8820444
[TBL] [Abstract][Full Text] [Related]
54. U.S. screening mammography services with mobile units: results from the National Survey of Mammography Facilities.
Brown ML; Fintor L
Radiology; 1995 May; 195(2):529-32. PubMed ID: 7724778
[TBL] [Abstract][Full Text] [Related]
55. Revolution follows the breast cancer epidemic.
Evans N
Revolution; 1996; 6(2):30-1. PubMed ID: 9043377
[No Abstract] [Full Text] [Related]
56. Budget impact analysis of switching to digital mammography in a population-based breast cancer screening program: a discrete event simulation model.
Comas M; Arrospide A; Mar J; Sala M; Vilaprinyó E; Hernández C; Cots F; Martínez J; Castells X
PLoS One; 2014; 9(5):e97459. PubMed ID: 24832200
[TBL] [Abstract][Full Text] [Related]
57. The cost-effectiveness of screening mammography beyond age 65 years: a systematic review for the U.S. Preventive Services Task Force.
Mandelblatt J; Saha S; Teutsch S; Hoerger T; Siu AL; Atkins D; Klein J; Helfand M;
Ann Intern Med; 2003 Nov; 139(10):835-42. PubMed ID: 14623621
[TBL] [Abstract][Full Text] [Related]
58. Cost-effectiveness analysis of mammography and clinical breast examination strategies: a comparison with current guidelines.
Ahern CH; Shen Y
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):718-25. PubMed ID: 19258473
[TBL] [Abstract][Full Text] [Related]
59. Why question screening mammography for women in their forties?
Fletcher SW
Radiol Clin North Am; 1995 Nov; 33(6):1259-71. PubMed ID: 7480669
[TBL] [Abstract][Full Text] [Related]
60. Mobile mammographic screening of self-referred women: results of 22,540 screenings.
Dershaw DD; Liberman L; Lippin BS
Radiology; 1992 Aug; 184(2):415-9. PubMed ID: 1620839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
